# Poolbeg Pharma in-licencing exciting programmes ready for big pharma (Interview)

- Link: https://www.directorstalkinterviews.com/poolbeg-pharma-in-licencing-exciting-programmes-ready-for-big-pharma-interview/4121044628
- Published: 2022-01-18T07:54:38+00:00
- Author: Giles

**[Poolbeg Pharma plc](https://www.directorstalkinterviews.com/company/poolbeg-pharma-plc/polb.l)**(
[LON:POLB](https://www.directorstalkinterviews.com/company/poolbeg-pharma-plc/polb.l))
CEO Jeremy Skillington joins DirectorsTalk Interviews to discuss the in-licencing
of a novel, first-in-class RNA-based immunotherapy for respiratory virus infections.

Jeremy tells us more about this new deal, explains the terms, what being at a late
pre-clinical stage means and explains the ultimate plan for this asset.

Poolbeg Pharma ([LON: POLB](https://www.directorstalkinterviews.com/company/poolbeg-pharma-plc/polb.l))
is a clinical stage infectious disease pharmaceutical company, with a clinical model
which enables them to develop multiple products faster and more cost effectively
than a traditional biotech model.

Share on: